More articles from From The Editor
- Talking to patients: Barriers to overcome
Not all patients think like doctors, but we need to be able to think like patients.
- Quality, frailty, and common sense
Ideal management of the frail elder with severe congestive heart failure is not always a matter of devices and drugs.
- The bittersweet of steroid therapy
Every physician has had patients with the long-term effects of glucocorticoid therapy, including diabetes.
- A discussion of dissection
Few medical emergencies are as dramatic as an acutely rupturing aortic aneurysm. Advances in research offer potential for more alternatives to emergency surgery.
- When to stop treating the bones
Don’t let the argument about how long to treat osteoporosis with bisphosphonate drugs stand in the way of initiating therapy in patients at risk of fracture.
- Out of Morpheus’ embrace
We still lack a full understanding of the complex physiology of sleep and the effects of sleep deprivation on a number of clinical conditions, from diabetes to fi bromyalgia.
- When good drugs turn weirdly bad
Even the most specific of drugs, such as interferon, can have untoward biologic effects.
- The pain of cholesterol-lowering therapy
It seems that everyone “knows” that statins cause muscle pain, including many patients with hypercholesterolemia.
- Recognizing the unusual: The diagnostic epiphany
We have all experienced the sudden recognition of an unexpected diagnosis, such as the case of visceral angioedema due to angiotensin-converting enzyme therapy reported by Korniyenko et al in this issue of the Journal.